Research Article

Efficacy and Safety of Modified Duhuo Jisheng Decoction in the Treatment of Lumbar Disc Herniation: A Systematic Review and Meta-Analysis

Table 1

Characteristics of all the trials included in the meta-analysis.

AuthorsCountryStudy typeSample size D : CMean age (years) D : CGender M : FInterventionTreatment duration (days)

Li and He [3]ChinaRCTs124 (64/60)38.5/37.6114/103 times, 100 mL, every day
DSSRC, 1 time, 100 mg, every day
20
20
Li [6]ChinaRCTs100 (50/50)52.2/53.146/542 times, every day
DL-LAP, 4 times, 900 mg, every day
NP
NP
Li [10]ChinaRCTs84 (42/42)49.5/49.549/353 times, 100 mL, every day
DSSRC, 1 time, 100 mg, every day
NP
NP
Ma [4]ChinaRCTs80 (40/40)48.5/4845/353 times, 250 mL, every day
aceclofenac, 2 times, 100 mg, every day
30
20
Ma et al. [5]ChinaRCTs68 (34/34)48.3/48.341/272 times, every day
DSECT, 3 times, 25 mg, every day
21
21
Mao [7]ChinaRCTs124 (64/60)39.5/38.698/263 times, 100 mL, every day
meloxicam, 1 time, every day
20
20
Rui and Zhao [12]ChinaRCTs100 (50/50)38.8/39.480/20NP
DSECT, 1 time, 100 mg, every day
NP
28
Wang and Yang [9]ChinaRCTs100 (50/50)NP65/352 times, every day
3 times, DSECT, 25 mg; ibuprofen, 200 mg; indomethacin, 25 mg, every day
15
15
Wei and Yang [11]ChinaRCTs64 (32/32)41.5/43.238/262 times, every day
NP
28
NP
Xie and Du [8]ChinaRCTs132 (66/66)NPNP3 times, every day
2 times, ICST, 213 mg; mannitol, 250 ml; vitamin B1, 10 mg, every day
21
21
Xue [16]ChinaRCTs60 (30/30)40.5/40.237/232 times, every day
DSECT, 3 times, 25 mg, every day
21
21
Zhang et al. [14]ChinaRCTs350 (175/175)42.8/41.7189/1612 times, every day
DSECT, 1 time, 100 mg, every day
14
14
Zhang and Zhong [15]ChinaRCTs100 (50/50)NP49/513 times, 250 mL, every day
DSECT, 2 times, 100 mg, every day
20
20
Zou [13]ChinaRCTs74 (37/37)55.2/55.441/331 time, every day
NP
30
30

DHJSD: Duhuo Jisheng Decoction; RCTs: randomized controlled trials; DSSRC: diclofenac sodium sustained-release capsule; DSECT: diclofenac sodium enteric-coated tablets; DL-LAP: DL-Lysine Aspirin Powder; ICST: ibuprofen codeine sustained tablets; NP: not provided. D: DHJSD group, C: control group.